Podcast summary & analysis
Can standard cholesterol tests miss your heart-disease risk?
Why a fit cardiovascular surgeon still had a heart attack, and the markers he wishes he'd checked.
Heart disease is common and often silent until a crisis, so how you measure risk really matters. A cholesterol result within the normal range does not by itself mean your overall risk is low, and an established marker like ApoB can sometimes refine that picture. Fasting insulin and insulin resistance tell you more about metabolism, which links heart health to blood sugar and weight, but they are less settled as routine heart-risk tests.
What this episode covers
- A standard cholesterol test does not always capture who is at risk for heart disease.
- In this episode a cardiovascular surgeon, who had a heart attack despite looking fit, argues for looking further, especially at ApoB.
- ApoB is a blood test that measures a protein carried by the cholesterol particles that can contribute to plaque in the arteries; because each of these particles carries one ApoB molecule, the result reflects how many of these potentially harmful particles are circulating.
- He also points to markers of insulin resistance, like fasting insulin, and to everyday drivers of risk such as poor sleep, ultra-processed food, and inflammation.
- ApoB is an established heart-risk marker that can refine a standard panel; fasting insulin tells you more about metabolism than about routine heart-risk decisions.
Confidence in this episode
Everything about how much to believe this episode, in one place.
This rates the episode as a whole. Confidence is high in its central point, that a standard cholesterol test does not capture all heart risk and that ApoB is an established marker. It is more moderate on the wider recommendations, such as routine fasting insulin testing and extensive advanced testing, whose added value for most people is less settled.
- ApoB is a blood test that reflects the number of cholesterol particles that can build plaque, and it is an established heart-risk marker.
- A standard cholesterol panel is only one part of heart-risk assessment and can miss risk in some people.
- Sleep, diet, activity, and blood-sugar control influence heart-disease risk.
- How much ApoB testing improves outcomes for most people over standard risk tools.
- Whether routine fasting insulin testing changes heart-disease decisions, rather than just describing metabolism.
- Which higher-risk groups gain the most from advanced testing.
What stands out
- A cholesterol result within the normal range does not by itself mean your overall heart risk is low.
- ApoB reflects the number of these risky particles, which can add information even when standard cholesterol results look reassuring.
- Being fit on the outside does not guarantee healthy arteries.
1Best-supported action
The single highest-leverage move from this episode, anchored in the strongest evidence the speaker presents.
If you are worried about heart risk, consider asking your doctor whether an ApoB test would add useful information to your standard cholesterol panel.
2Where to start
Small low-friction starters covering the main moves from this episode.
- Focus on the lifestyle foundations: activity, sleep, diet quality, and blood sugar.
- Ask whether an ApoB test adds useful information to your standard panel.
- Track your risk factors over time with your doctor, including blood pressure and smoking.
3Other supported actions
Further actions discussed in this episode, ordered from strongest to weakest evidence. This is one expert's view, the full topic compares and ranks across experts.
- Consider focusing on the established lifestyle foundations discussed in the episode, such as regular physical activity, adequate sleep, dietary quality, and blood-sugar management where relevant.Strong evidence
- Consider asking your doctor whether an ApoB test would add useful information to your standard cholesterol panel.Moderate evidence
- If your standard results look fine but you have other risk factors, consider asking whether your overall heart risk is being fully assessed, including blood pressure, smoking, and family history.Moderate evidence
Questions worth asking your doctor
- Given my heart-risk history, would an ApoB test add useful information beyond my standard cholesterol panel?
- Given my results so far, am I actually at low risk, or could my lipid panel be missing part of the picture?
- Given my situation, what lifestyle changes and standard treatments would most lower my heart-disease risk?
Full doctor prep with ranked questions available in the full topic page
Context
This does not prove that everyone needs advanced tests. Not everyone needs extra biomarker testing beyond standard cardiovascular risk assessment.
ApoB and fasting insulin are not the same kind of test. ApoB is an established heart-risk marker; fasting insulin reflects metabolic health and is much less established for routine heart-risk decisions.
A single test result, standard or advanced, does not decide your risk on its own. Doctors weigh several factors together, including blood pressure, smoking, diabetes, and family history.
The episode comes from a functional-medicine show, which tends to favor extensive testing. That framing is worth keeping in mind, though ApoB itself is an established cardiovascular risk marker.
This is general information, not medical advice. It does not mean you should change or stop any current treatment on your own. Decide testing and treatment with your doctor.
Where people go wrong
- Assuming a cholesterol result in the normal range means your overall heart risk is low.You may miss risk that a fuller assessment would catch.
- Chasing every advanced test without a plan to act on the results.You may spend money and worry without changing what actually helps.
What to expect over time
- NowKnow that a cholesterol result in the normal range does not fully rule out heart risk.
- At your next visitAsk whether an established marker like ApoB fits your situation.
- OngoingWork on activity, sleep, diet, and blood sugar, and track risk factors over time.